Ruxolitinib

Red

Brand Name(s):Jakavi

Indication:Myelofibrosis – Chronic idiopathic myelofibrosis and treatment of myelofibrosis secondary to polycythaemia vera or essential thrombocythaemia

Rationale:1,2

Considered:May-12

Review Date:Apr-21

Comments:
NICE TA 386
March 2016